Novel assessment tools to evaluate clinical and laboratory responses in a subset of patients enrolled in the Rituximab in Myositis trial

We aimed to assess changes in myositis core set measures and ancillary clinical and laboratory data from the National Institutes of Health's subset of patients enrolled in the Rituximab in Myositis trial. Eighteen patients (5 dermatomyositis, 8 polymyositis, 5 juvenile dermatomyositis) complete...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical and experimental rheumatology 2014-09, Vol.32 (5), p.689-696
Hauptverfasser:	Rider, Lisa G, Yip, Adrienne L, Horkayne-Szakaly, Iren, Volochayev, Rita, Shrader, Joseph A, Turner, Maria L, Kong, Heidi H, Jain, Minal S, Jansen, Anna V, Oddis, Chester V, Fleisher, Thomas A, Miller, Frederick W
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Adult Anti-Inflammatory Agents - therapeutic use Antibodies, Monoclonal, Murine-Derived - therapeutic use B-Lymphocytes - drug effects B-Lymphocytes - immunology Biomarkers - blood Child Female Health Status Indicators Humans Male Middle Aged Muscle Strength - drug effects Myositis - blood Myositis - diagnosis Myositis - drug therapy Myositis - physiopathology Predictive Value of Tests Recovery of Function Remission Induction Rituximab Skin - drug effects Skin - pathology Surveys and Questionnaires Time Factors Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!